Assessment of the mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) in the isolated toad bladder.
D000818:Animals; D001001:Anura; D001681:Biological Assay; D001693:Biological Transport, Active / Q000187:drug effects*; D003900:Desoxycorticosterone / Q000494:pharmacology; D005438:Fludrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D008901:Mineralocorticoids / Q000494:pharmacology*; D011278:Pregnanes / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism*; D013148:Spironolactone / Q000494:pharmacology; D013268:Stimulation, Chemical; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology*
D008901:Mineralocorticoids; D011278:Pregnanes; D013148:Spironolactone; D003900:Desoxycorticosterone; D012964:Sodium; D005438:Fludrocortisone